Virginia Commonwealth University
http://www.vcu.edu
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Virginia Commonwealth University
Deal Watch: Dianthus Will Reach Public Markets Via Reverse Merger With Stalled-Out Magenta
After shutting down its trial for a leukemia conditioning agent due to a patient death, Magenta’s review of strategic alternatives concludes with a combination with complement inhibitor-focused Dianthus.
Tech Transfer Roundup: Hoth Teams With VCU On Therapy To Block COVID-19 Replication
Pandemic-related collaborations between Hoth/VCU; Sorrento/Mt. Sinai Health; Audax/Northeastern U.; Alkido/U. of Maryland, Baltimore; Active Motif/Hisun BioRay/Fudan U. and more.
Deals Shaping The Medical Industry, September 2014
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced June-August 2014.
Heightened Concussion Awareness Calls For New Detection Tools
Medical device start-ups are surging into new territory in mild traumatic brain injury or concussion detection, which has heretofore lacked objective diagnostics and monitoring tools. Profiles of Cerora, MC10, Oculogica, and Sway Medical.
Company Information
- Industry
- Academic and Research Institutions
- Other Names / Subsidiaries
-
- VCU
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice